Fig. 3.

NL-1 reduces maximal ocr of differentiated CSCs. a Absolute oxygen consumption rate (OCR) of CSCs following a 7-day differentiation protocol under the specified treatment conditions, represented as pmol O₂/min/mg protein. b OCR and d extracellular acidification rate (ECAR) of CSC represented as percent baseline (baseline is defined as OCR or ECAR at time point immediately preceding FCCP or oligomycin administration, respectively). c Maximal OCR as measured during the first three time points after FCCP administration and represented as percent baseline. e Maximal ECAR as measured during the first three time points following oligomycin administration and represented as percent baseline. **p < 0.01 vs. undifferentiated. ^#p < 0.01 vs. both DM and DM + vehicle. *p < 0.05 vs. both DM and DM + vehicle. N = 4. DM dexamethasone-treated CSCs